Agilon Health Inc (NYSE:AGL) price on Wednesday, May 21, fall -5.24% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $2.35.
A look at the stock’s price movement, the close in the last trading session was $2.48, moving within a range at $2.31 and $2.4366. The beta value (5-Year monthly) was 0.387. Turning to its 52-week performance, $7.73 and $1.50 were the 52-week high and 52-week low respectively. Overall, AGL moved -41.83% over the past month.
Agilon Health Inc’s market cap currently stands at around $972.79 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-05.
Analysts have a consensus estimate of 1.47B for the company’s revenue for the quarter, with a low and high estimate of 1.46B and 1.5B respectively. The average forecast suggests down to a -0.68% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 5.96B, representing a -1.71% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AGL is a 100% Sell. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
10 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 7 recommend AGL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AGL’s current price about -29.11% and -41.75% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 30.98, while 7-day volatility ratio is 7.47% and 10.08% in the 30-day chart. Further, Agilon Health Inc (AGL) has a beta value of 0.15, and an average true range (ATR) of 0.35. Analysts have given the company’s stock an average 52-week price target of $4, forecast between a low of $2.5 and high of $6.5. Looking at the price targets, the low is -6.38% off current price level while to achieve the yearly target high, price needs to move -176.6%. Nonetheless, investors will most likely welcome a -70.21% jump to $4 which is the analysts’ median price.
If we refocus on Agilon Health Inc (NYSE:AGL), historical trading data shows that trading volumes averaged 4.68 over the past 10 days and 6.09 million over the past 3 months. The company’s latest data on shares outstanding shows there are 413.02 million shares.
The 26.86% of Agilon Health Inc’s shares are in the hands of company insiders while institutional holders own 73.48% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 21.96 million on 2025-04-30, giving us a short ratio of 3.32. The data shows that as of 2025-04-30 short interest in Agilon Health Inc (AGL) stood at 870.9999999999999 of shares outstanding, with shares short rising to 18.27 million registered in 2025-03-31. Current price change has pushed the stock 23.68% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AGL stock continues to rise going into the next quarter.
